Risk factors associated with the development of oral mucositis in pediatric oncology patients: Systematic review and meta‐analysis

Objectives Oral mucositis (OM) is an acute toxicity related to cancer treatment. This systematic review aimed to identify potential risk factors associated with the development of OM in pediatric cancer patients. Methods A search was performed in four electronic databases to identify studies that an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral diseases 2022-05, Vol.28 (4), p.1068-1084
Hauptverfasser: Farias Gabriel, Amanda, Silveira, Felipe Martins, Curra, Marina, Schuch, Lauren Frenzel, Wagner, Vivian Petersen, Martins, Marco Antonio Trevizani, Silveira Matte, Ursula, Siebert, Marina, Botton, Mariana Rodrigues, Brunetto, André Tesainer, Gregianin, Lauro José, Martins, Manoela Domingues
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives Oral mucositis (OM) is an acute toxicity related to cancer treatment. This systematic review aimed to identify potential risk factors associated with the development of OM in pediatric cancer patients. Methods A search was performed in four electronic databases to identify studies that analyzed risk factors for OM in pediatric cancer patients. Results Nineteen articles were included. The incidence of OM ranged from 20% to 80.4%. Chemotherapeutic agents were potential risk factors for OM in eight (42%) studies. Hematological, hepatic, and renal parameters were also considered in eight (42%) studies, while specific individual factors were reported in five (26.3%) studies. Baseline disease, oral microbiota, genetic profile, and biomarkers were reported in four (21.5%) studies each. Meta‐analysis showed that groups submitted to high‐risk chemotherapy for OM had a 2.79‐fold increased risk of OM. Conclusions Identifying risk factors for OM is essential in order to allow individualized and early prevention treatment.
ISSN:1354-523X
1601-0825
DOI:10.1111/odi.13863